Jingxin Pharmaceutical announced on the evening of July 27 that the company intends to purchase the shares and pay cash to display the 90% stake in Juju. Previously, another medical device company, Yuyue Medical, also issued an announcement and signed a strategic cooperation framework agreement with Pfizer Investment. In just one month, there were two medical device companies and "pharmaceutical companies", and the cooperation announcements issued by the two companies involved the development and use of drug-integrated products in the field of chronic diseases.
From finding problems to solving problems, strong cooperation or future trends
At present, the development of China's medical device enterprises is still quite different from that of foreign countries. The potential of China's medical device market has yet to be tapped, and the cooperation between medical device companies and pharmaceutical companies is, to a certain extent, an advantage. The complementarity of resources. "Medical devices in the chronic disease market mainly use advanced science and technology to discover and diagnose chronic diseases, while the chronic disease management of pharmaceutical companies is conducive to the resolution of chronic diseases. Therefore, the two are 'discovering problems' and 'solving problems'. The relationship. "Yang Gucheng, deputy general manager of Yangpu Medical Health Division, told reporters.
In addition, Ma Zhaohui, Chairman of Qingdao Hainuo Biotechnology Co., Ltd. analyzed: "China's medical device market started late, and now cooperates with pharmaceutical companies to take advantage of the quality management technology of pharmaceutical companies, and the good policy environment and huge medical equipment. The development space forms complementary advantages, submits the quality of medical devices, and develops high-end medical device products. "At the same time, Ma Zhaohui revealed to reporters that Heinuo has also reached cooperation with several pharmaceutical companies to prepare for the advantages of both sides and seek medical equipment. Cooperation and development in the field, "At present, the differentiation of domestic medicine and equipment industry is still serious. If high-end equipment and medicine can be united, it is a good thing."
In the current medical industry is seeking transformation and development, industry experts believe that the combination of medical equipment will become a development trend in the future. "Now the residents' self-medication awareness is gradually improving. Under the background of the standardization of medication and the release of dividends from the pharmaceutical industry policy, especially the 'Internet +' policy proposed this year is good for the entire medical device industry . Therefore, the strong alliance of medical equipment will become a development trend." Ye Gucheng told reporters.
Seeking 1+1 is greater than 2
Complementary resources or unequal
Chen Zhonglin, deputy director and executive secretary of the Medical Device Professional Committee of China Pharmacy Management College and chairman of Jiangsu Zhonglin Medical Technology Development Co., Ltd., is not optimistic about the marriage of medical equipment. "From the perspective of sales, medical device companies and pharmaceutical companies The sales team and the sales concept itself are very different. The two may not be integrated, and they will not become the trend of the medical device industry. "There are experts who believe that the cooperation between the two drugs is only to achieve 1+1 greater than 2 effect. However, the complementary resources of these are not equal. They can only be said that they have complementary possibilities in the channels. For Pittsburgh and Pfizer, Pfizer has a deeper plan to cooperate with it. The company has a very strong channel resource in the country, which can help Pfizer's development in the chronic disease market and medical devices. Pfizer is likely to want to use fish. Leap this powerful platform to clear the channels of prescription drugs. But in turn, it seems that it is difficult for Yuyue to use Pfizer's pharmaceutical market resources.
Plastic centrifuge tubes are commonly used in the laboratory. Since glass centrifuge tubes cannot be used in high-speed or ultra-high-speed centrifugates, plastic centrifuge tubes are generally used more.
Scientists often use centrifuge tubes to separate solids, liquids, and gases. You can separate solid particles from liquids, like plasma and blood cells. You can do this by spinning the Centrifuge tube that carries the material at high speed. The centrifuge tube allows centrifugal force to push heavier material to the bottom of the tube. The centrifuge tube facilitates the preservation of samples to be separated by centrifugation. Typically, these centrifuge tubes can handle a small number of samples. Researchers used different types of centrifuge tubes for different tasks and procedures.
Centrifuge tubes are essential for sample separation, delamination, or density gradient separation using centrifuges. Centrifuge tubes have a variety of applications in biology, particularly cell culture and microbiology, chemistry, clinical healthcare, and wider industrial Settings.
Microcentrifuge, Conical Tube, Microfuge Tube, Falcon Tubes 15ml
Ningbo Siny Medical Technology Co., Ltd , https://www.sinymedical.com